Phibro Animal Health Co. (NASDAQ:PAHC) Shares Purchased by Fmr LLC

Fmr LLC raised its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 22.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,310 shares of the company’s stock after purchasing an additional 7,270 shares during the quarter. Fmr LLC’s holdings in Phibro Animal Health were worth $885,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in PAHC. CWM LLC lifted its holdings in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the last quarter. nVerses Capital LLC purchased a new stake in Phibro Animal Health in the third quarter valued at $70,000. Summit Securities Group LLC acquired a new position in shares of Phibro Animal Health in the 2nd quarter valued at $83,000. China Universal Asset Management Co. Ltd. lifted its stake in shares of Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. Finally, Algert Global LLC purchased a new position in shares of Phibro Animal Health during the 2nd quarter worth $193,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Down 0.1 %

Shares of PAHC opened at $22.64 on Tuesday. The company’s 50-day simple moving average is $23.61 and its 200-day simple moving average is $20.58. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health Co. has a 1 year low of $10.03 and a 1 year high of $25.98. The stock has a market capitalization of $916.99 million, a PE ratio of 52.56, a P/E/G ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.12%. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Wall Street Analyst Weigh In

A number of research analysts have commented on PAHC shares. Bank of America upped their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective on the stock. StockNews.com downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Friday, December 6th. Finally, Barclays upped their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.